Patents by Inventor Revital Ben-Daniel

Revital Ben-Daniel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10280173
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: May 7, 2019
    Assignee: WAVELENGTH ENTERPRISES LTD
    Inventors: Itai Adin, Sonia Krivonos, Yevgeny Rozenblat, Alex Weisman, Ana Fernandez Casares, Gloria Ten Figas, Revital Ben-Daniel
  • Publication number: 20180251463
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Application
    Filed: December 22, 2017
    Publication date: September 6, 2018
    Applicant: WAVELENGTH ENTERPRISES LTD.
    Inventors: Itai ADIN, Sonia KRIVONOS, Yevgeny ROZENBLAT, Alex WEISMAN, Ana FERNANDEZ CASARES, Gloria TEN FIGAS, Revital BEN-DANIEL
  • Patent number: 9884869
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: February 6, 2018
    Assignee: PERRIGO API LTD.
    Inventors: Itai Adin, Sonia Krivonos, Yevgeny Rozenblat, Alex Weisman, Ana Fernadez Casares, Gloria Ten Figas, Revital Ben-Daniel
  • Publication number: 20170226108
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Application
    Filed: March 23, 2015
    Publication date: August 10, 2017
    Applicant: PERRIGO API LTD.
    Inventors: Itai ADIN, Sonia KERIVONOS, Yevgeny ROZENBLAT, Alex WEISMAN, Ana FERNADEZ CASARES, Gloria TEN FIGAS, Revital BEN-DANIEL
  • Patent number: 6762310
    Abstract: The invention provides a process for the catalytic epoxidation of an alkene comprising a transition metal substituted polyoxofluorometalate and molecular oxygen with the alkene. The invention also includes transition metal substituted polyoxofluorometalates of the formula Qq[NaH2(TM)(H2O)M17F6O55]q and the molecular structure depicted in FIG. 1, where M is Mo, W, Nb, V or combinations thereof, TM is selected from Ti, V, Cr, Mn Fe, Co, Ni, Cu, Zn and the noble metals Ru, Pd, Rh, Ir, Os and Pt,, and Q is a countercation countering the charge q−, and a process for preparing such polyoxofluorometalates.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: July 13, 2004
    Assignees: Yissum Research Development Company of Hebrew University of Jersualem, Yeda Research and Development Company Ltd.
    Inventors: Ronny Neumann, Alexander Khenkin, Revital Ben-Daniel
  • Publication number: 20030181739
    Abstract: The invention provides a process for the catalytic epoxidation of an alkene comprising contacting a transition metal substituted polyoxofluorometalate and molecular oxygen with said alkene.
    Type: Application
    Filed: March 25, 2003
    Publication date: September 25, 2003
    Applicants: Yeda Research and Development Company Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Ronny Neumann, Alexander Khenkin, Revital Ben-Daniel
  • Patent number: 6573394
    Abstract: The invention provides a process for the catalytic epoxidation of an alkene comprising contacting a transition metal substituted polyoxofluorometalate and molecular oxygen with said alkene.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: June 3, 2003
    Assignees: Yissum Research Development Company of Hebrew University of Jerusalem, Yeda Research and Development Company Ltd.
    Inventors: Ronny Neumann, Alexander Khenkin, Revital Ben-Daniel